• TOP1, cGAS, and PD-L1 in Cervical Cancer

  2026-08-26

  Luo et al. identify topoisomerase I as a DNA repair and immune-regulatory mediator linking HPV E6/E7 activity to cGAS-dependent PD-L1 expression in cervical cancer. The study supports the TOP1–cGAS–PD-L1 axis as a mechanistic framework for understanding tumor growth and immune evasion, while also defining experimental considerations for future cervical cancer research.

• Resazurin sodium salt in Cell Viability Workflows

  2026-08-26

  Resazurin sodium salt converts cellular redox activity into a practical fluorescence endpoint for proliferation, cytotoxicity, imaging, and screening workflows. This guide shows how to deploy it alongside osteogenic pathway assays, especially when interpreting pharmacological studies of Wnt signaling and sclerosteosis models.

• Letrozole: From Enzyme Inhibition to Assay Design

  2026-08-25

  Letrozole is a reversible non-steroidal aromatase inhibitor for precisely studying estrogen depletion, receptor signaling, and FSH release modulation. This guide moves beyond compound description to show how assay architecture determines whether endocrine findings are mechanistically interpretable.

• Foxp1, Notch, and Valvular Calcification in CKD

  2026-08-25

  A 2026 Biochemical Pharmacology study identifies endothelial Foxp1 as a suppressor of CKD-related valvular calcification by repressing Jagged-1/Notch signaling and limiting endothelial-to-mesenchymal transition. Its mouse and cell-based evidence connects endothelial barrier preservation with reduced TGF-β1-driven osteogenic activation of valvular interstitial cells and lower inflammatory recruitment.

• Cucurbitacin I: From STAT3 Probe to Translation

  2026-08-24

  Cucurbitacin I, also known as JSI-124, is most valuable as a causal STAT3 perturbation tool rather than a standalone cytotoxicity reagent. This thought-leadership guide shows how to connect pathway engagement with phenotype, model complexity, and translational decision-making while using a human SAN-plexus assembloid study as a disciplined lesson in biological context.

• HOBt: From Coupling Fidelity to Translational Design

  2026-08-24

  HOBt is more than a conventional coupling additive: it is a strategic control point for amide bond formation, stereochemical fidelity, and medicinal chemistry decision-making. Using an indazole- and indole-based glucagon receptor antagonist study as an anchor, this article connects reaction mechanism with SAR quality, preclinical interpretation, and practical reagent management.

• GLP-1 (9-36) amide: Reliable GLP-1R Assays

  2026-08-23

  This scenario-based guide explains how GLP-1 (9-36) amide, SKU B5404, can support controlled GLP-1 receptor signaling research while addressing peptide solubility, assay interpretation, and handling risks. It connects product specifications with published evidence on cAMP-based GLP-1R pharmacology and practical cell-based workflow design.

• BOP Reagent: Reliable Peptide Coupling

  2026-08-22

  Learn how BOP reagent supports controlled carboxyl group activation and amide bond formation upstream of cell viability and cytotoxicity assays. This scenario-based guide explains handling, solvent compatibility, data interpretation, and vendor selection for SKU A7015.

• Sulfo-NHS-SS-Biotin for AML Surface Proteomics

  2026-08-22

  Sulfo-NHS-SS-Biotin enables cell-impermeant surface labeling, reversible affinity capture, and disulfide-based release in one workflow. This guide translates recent AML cell-surface biology into practical enrichment, validation, and troubleshooting strategies for protein purification and surface proteomics.

• Canagliflozin Hemihydrate: Research Workflows

  2026-08-21

  Build more reproducible SGLT2 experiments with a practical workflow for Canagliflozin hemihydrate, from solvent preparation and glucose-transport assays to pathway-specific controls. The article also shows how a drug-sensitized yeast platform can serve as a valuable mTOR counter-screen without confusing metabolic activity with TOR inhibition.

• BIBP 3226: A Causal Probe for Cardiac Arrhythmia

  2026-08-20

  BIBP 3226 trifluoroacetate provides a defined pharmacological probe for separating NPY Y1 and NPFF signaling in mechanistic studies. This article translates the adipose-neural arrhythmia model into practical assay logic, controls, and interpretation strategies.

• Brassinolide for Reproducible Cell Assays

  2026-08-20

  This scenario-driven guide explains how Brassinolide, SKU A3265, can be incorporated into cell viability, proliferation, and apoptosis workflows without confusing solvent effects with biological activity. It covers formulation, assay controls, interpretation of PC-3 apoptosis evidence, and practical product-selection criteria for biomedical laboratories.

• ATP Solution for mRNA-LNP Workflows

  2026-08-19

  Discover how a high-purity ATP Solution supports IVT mRNA production, kinase validation, ligation, and phosphorylation assays connected to localized p21 mRNA-LNP research. Practical dilution guidance, workflow controls, and troubleshooting help translate Adenosine-5'-triphosphate handling into more reproducible molecular biology experiments.

• Cationic Lipid Pairs Redirect mRNA LNPs to the Lung

  2026-08-19

  Zeng and colleagues developed a cationic lipid pair strategy that combines a liver-targeted ionizable lipid with its quaternary ammonium derivative to shift four-component lipid nanoparticles from liver-biased toward lung-enriched mRNA delivery. The study shows that parent-lipid performance is an important design criterion and that the approach can be extended to clinically used ionizable lipids, including SM-102 and ALC-0315.

• Z-VDVAD-FMK for Caspase-2 Apoptosis Workflows

  2026-08-18

  Z-VDVAD-FMK helps researchers test whether caspase-2 contributes to mitochondrial and nuclear apoptosis, while its activity against caspases-3 and -7 requires careful interpretation. This workflow guide connects inhibitor treatment with caspase activity measurement, cytochrome c analysis, DDX23 signaling, and orthogonal cell-death readouts.

8356 records 1/558 page Next 12345 下5页 Last page